Your browser doesn't support javascript.
loading
Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results from the CBMTR.
Xu, Lanping; Lu, Yue; Chen, Jing; Sun, Shuwen; Hu, Shaoyan; Wang, Shunqing; Wu, Xuedong; Sun, Yuan; Wan, Dingming; Xu, Yajing; Jiang, Hui; Li, Chunfu; Lan, Mei; Jiang, Erlie; Li, Fei; Liu, Sixi; Tang, Yongmin; Lin, Fan; Lu, Peihua; Luo, Chengjuan; Huang, Xiaojun.
Afiliación
  • Xu L; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
  • Lu Y; Hebei Yanda Lu Daopei Hospital & Beijing Ludaopei Hospital, Langfang & Beijing, China.
  • Chen J; Shanghai Children's Medical Center, Shanghai, China.
  • Sun S; West China Second University Hospital, Sichuan University/ West China Women's and Children's Hospital, Chengdu, China.
  • Hu S; Children's Hospital of Soochow University, Soochow, China.
  • Wang S; Guangzhou First People's Hospital, Guangzhou, China.
  • Wu X; Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Sun Y; Beijing Jingdu Children's Hospital, Beijing, China.
  • Wan D; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Xu Y; Xiangya Hospital, Central South University, Changsha, China.
  • Jiang H; Shanghai Children's Hospital, Shanghai, China.
  • Li C; Nanfang-Chunfu Children's Institute of Hematology & Oncology, Taixin Hospital, Dongguan, China.
  • Lan M; The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China.
  • Jiang E; Institute of Hematology & Blood Diseases hospital, Chinese Academy of Medical Sciences, Tianjin, China.
  • Li F; The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu S; Shenzhen Children's Hospital, Shenzhen, China.
  • Tang Y; The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
  • Lin F; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China.
  • Lu P; Hebei Yanda Lu Daopei Hospital & Beijing Ludaopei Hospital, Langfang & Beijing, China.
  • Luo C; Shanghai Children's Medical Center, Shanghai, China.
  • Huang X; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Collaborative Innovation Center of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplant, Beijing, China. huangxiaojun@bjmu.edu.cn.
Bone Marrow Transplant ; 58(1): 106-108, 2023 01.
Article en En | MEDLINE | ID: mdl-36257981
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Anemia de Fanconi / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Anemia de Fanconi / Enfermedad Injerto contra Huésped Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido